Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2012 Jun 22;3(9):648–660. doi: 10.1007/s13238-012-2043-4

Mitochondria in the pathogenesis of diabetes: a proteomic view

Xiulan Chen 1, Shasha Wei 1,2, Fuquan Yang 1,✉
PMCID: PMC4875370  PMID: 22729395

Abstract

Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia due to absolute or relative lack of insulin. Though great efforts have been made to investigate the pathogenesis of diabetes, the underlying mechanism behind the development of diabetes and its complications remains unexplored. Cumulative evidence has linked mitochondrial modification to the pathogenesis of diabetes and its complications and they are also observed in various tissues affected by diabetes. Proteomics is an attractive tool for the study of diabetes since it allows researchers to compare normal and diabetic samples by identifying and quantifying the differentially expressed proteins in tissues, cells or organelles. Great progress has already been made in mitochondrial proteomics to elucidate the role of mitochondria in the pathogenesis of diabetes and its complications. Further studies on the changes of mitochondrial protein specifically post-translational modifications during the diabetic state using proteomic tools, would provide more information to better understand diabetes.

Keywords: mitochondria proteomics, T1DM, T2DM, diabetes complication

References

  1. Akude E., Zherebitskaya E., Chowdhury S.K., Smith D.R., Dobrowsky R.T., Fernyhough P. Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes. 2011;60:288–297. doi: 10.2337/db10-0818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anello M., Lupi R., Spampinato D., Piro S., Masini M., Boggi U., Del Prato S., Rabuazzo A.M., Purrello F., Marchetti P. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia. 2005;48:282–289. doi: 10.1007/s00125-004-1627-9. [DOI] [PubMed] [Google Scholar]
  3. Bantscheff M., Schirle M., Sweetman G., Rick J., Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem. 2007;389:1017–1031. doi: 10.1007/s00216-007-1486-6. [DOI] [PubMed] [Google Scholar]
  4. Baseler W.A., Dabkowski E.R., Williamson C.L., Croston T.L., Thapa D., Powell M.J., Razunguzwa T.T., Hollander J.M. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol. 2010;300:R186–200. doi: 10.1152/ajpregu.00423.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., Shulman G.I. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 2007;56:1376–1381. doi: 10.2337/db06-0783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bindokas V.P., Kuznetsov A., Sreenan S., Polonsky K.S., Roe M.W., Philipson L.H. Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J Biol Chem. 2003;278:9796–9801. doi: 10.1074/jbc.M206913200. [DOI] [PubMed] [Google Scholar]
  7. Boudina S., Sena S., Theobald H., Sheng X., Wright J.J., Hu X.X., Aziz S., Johnson J.I., Bugger H., Zaha V.G., et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007;56:2457–2466. doi: 10.2337/db07-0481. [DOI] [PubMed] [Google Scholar]
  8. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia. 2007;50:790–796. doi: 10.1007/s00125-007-0594-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. doi: 10.2337/diabetes.54.6.1615. [DOI] [PubMed] [Google Scholar]
  10. Bugger H., Abel E.D. Mitochondria in the diabetic heart. Cardiovasc Res. 2010;88:229–240. doi: 10.1093/cvr/cvq239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bugger H., Boudina S., Hu X.X., Tuinei J., Zaha V.G., Theobald H.A., Yun U.J., McQueen A.P., Wayment B., Litwin S.E., et al. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes. 2008;57:2924–2932. doi: 10.2337/db08-0079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bugger H., Chen D., Riehle C., Soto J., Theobald H.A., Hu X.X., Ganesan B., Weimer B.C., Abel E.D. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes. 2009;58:1986–1997. doi: 10.2337/db09-0259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125:1241–1252. doi: 10.1016/j.cell.2006.06.010. [DOI] [PubMed] [Google Scholar]
  14. Chomentowski P., Coen P.M., Radikova Z., Goodpaster B.H., Toledo F.G. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab. 2011;96:494–503. doi: 10.1210/jc.2010-0822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., Yoon Y.S., Yoon G., Choi K.M., Ko Y.G. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia. 2006;49:784–791. doi: 10.1007/s00125-006-0170-2. [DOI] [PubMed] [Google Scholar]
  16. Chowdhury, S.K., Smith, D.R., and Fernyhough, P. (2012). The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol Dis (In Press). [DOI] [PubMed]
  17. Cui Z., Hou J., Chen X., Li J., Xie Z., Xue P., Cai T., Wu P., Xu T., Yang F. The profile of mitochondrial proteins and their phosphorylation signaling network in INS-1 beta cells. J Proteome Res. 2010;9:2898–2908. doi: 10.1021/pr100139z. [DOI] [PubMed] [Google Scholar]
  18. D’Hertog W., Mathieu C., Overbergh L. Type 1 diabetes: entering the proteomic era. Expert Rev Proteomics. 2006;3:223–236. doi: 10.1586/14789450.3.2.223. [DOI] [PubMed] [Google Scholar]
  19. Dabkowski E.R., Baseler W.A., Williamson C.L., Powell M., Razunguzwa T.T., Frisbee J.C., Hollander J.M. Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am J Physiol Heart Circ Physiol. 2010;299:H529–540. doi: 10.1152/ajpheart.00267.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dabkowski E.R., Williamson C.L., Bukowski V.C., Chapman R.S., Leonard S.S., Peer C.J., Callery P.S., Hollander J.M. Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol. 2009;296:H359–369. doi: 10.1152/ajpheart.00467.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Deng W.J., Nie S., Dai J., Wu J.R., Zeng R. Proteome, phosphoproteome and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics. 2010;9:110–116. doi: 10.1074/mcp.M900020-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Duchen M.R. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med. 2004;25:365–451. doi: 10.1016/j.mam.2004.03.001. [DOI] [PubMed] [Google Scholar]
  23. Eyrich B., Sickmann A., Zahedi R.P. Catch me if you can: mass spectrometry-based phosphoproteomics and quantification strategies. Proteomics. 2011;11:554–570. doi: 10.1002/pmic.201000489. [DOI] [PubMed] [Google Scholar]
  24. Fernyhough P., Roy Chowdhury S.K., Schmidt R.E. Mitochondrial stress and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol Metab. 2010;5:39–49. doi: 10.1586/eem.09.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446–1454. doi: 10.2337/db08-0057. [DOI] [PubMed] [Google Scholar]
  26. Graier W.F., Malli R., Kostner G.M. Mitochondrial protein phosphorylation: instigator or target of lipotoxicity? Trends Endocrinol Metab. 2009;20:186–193. doi: 10.1016/j.tem.2009.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Greenacre S.A., Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res. 2001;34:541–581. doi: 10.1080/10715760100300471. [DOI] [PubMed] [Google Scholar]
  28. Gregersen, N., Hansen, J., and Palmfeldt, J. (2012). Mitochondrial proteomics-a tool for the study of metabolic disorders. J Inherit Metab Dis. [DOI] [PubMed]
  29. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377. doi: 10.1038/nrm2391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hojlund K., Wrzesinski K., Larsen P.M., Fey S.J., Roepstorff P., Handberg A., Dela F., Vinten J., McCormack J.G., Reynet C., et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem. 2003;278:10436–10442. doi: 10.1074/jbc.M212881200. [DOI] [PubMed] [Google Scholar]
  31. Hood D.A. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol. 2001;90:1137–1157. doi: 10.1152/jappl.2001.90.3.1137. [DOI] [PubMed] [Google Scholar]
  32. Hu Y., Suarez J., Fricovsky E., Wang H., Scott B.T., Trauger S.A., Han W., Oyeleye M.O., Dillmann W.H. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem. 2009;284:547–555. doi: 10.1074/jbc.M808518200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kanwar M., Chan P.S., Kern T.S., Kowluru R.A. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007;48:3805–3811. doi: 10.1167/iovs.06-1280. [DOI] [PubMed] [Google Scholar]
  34. Kartha G.K., Moshal K.S., Sen U., Joshua I.G., Tyagi N., Steed M.M., Tyagi S.C. Renal mitochondrial damage and protein modification in type-2 diabetes. Acta Diabetol. 2008;45:75–81. doi: 10.1007/s00592-008-0025-z. [DOI] [PubMed] [Google Scholar]
  35. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944–2950. doi: 10.2337/diabetes.51.10.2944. [DOI] [PubMed] [Google Scholar]
  36. Kim J.A., Wei Y., Sowers J.R. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102:401–414. doi: 10.1161/CIRCRESAHA.107.165472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kotronen A., Seppala-Lindroos A., Bergholm R., Yki-Jarvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia. 2008;51:130–138. doi: 10.1007/s00125-007-0867-x. [DOI] [PubMed] [Google Scholar]
  38. Lamson D.W., Plaza S.M. Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment. Altern Med Rev. 2002;7:94–111. [PubMed] [Google Scholar]
  39. Leinninger G.M., Backus C., Sastry A.M., Yi Y.B., Wang C.W., Feldman E.L. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis. 2006;23:11–22. doi: 10.1016/j.nbd.2006.01.017. [DOI] [PubMed] [Google Scholar]
  40. Leinninger G.M., Edwards J.L., Lipshaw M.J., Feldman E.L. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2006;2:620–628. doi: 10.1038/ncpneuro0320. [DOI] [PubMed] [Google Scholar]
  41. Lesnefsky E.J., Slabe T.J., Stoll M.S., Minkler P.E., Hoppel C.L. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 2001;280:H2770–2778. doi: 10.1152/ajpheart.2001.280.6.H2770. [DOI] [PubMed] [Google Scholar]
  42. Lewis E.J., Lewis J.B. Treatment of diabetic nephropathy with angiotensin II receptor antagonist. Clin Exp Nephrol. 2003;7:1–8. doi: 10.1007/s101570300000. [DOI] [PubMed] [Google Scholar]
  43. Li J., Cai T., Wu P., Cui Z., Chen X., Hou J., Xie Z., Xue P., Shi L., Liu P., et al. Proteomic analysis of mitochondria from Caenorhabditis elegans. Proteomics. 2009;9:4539–4553. doi: 10.1002/pmic.200900101. [DOI] [PubMed] [Google Scholar]
  44. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., Ponomarenko A., DeCarli L.M. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004;79:502–509. doi: 10.1093/ajcn/79.3.502. [DOI] [PubMed] [Google Scholar]
  45. Lopez-Sanchez L.M., Lopez-Pedrera C., Rodriguez-Ariza A. Proteomics insights into deregulated protein S-nitrosylation and disease. Expert Rev Proteomics. 2012;9:59–69. doi: 10.1586/epr.11.74. [DOI] [PubMed] [Google Scholar]
  46. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384–387. doi: 10.1126/science.1104343. [DOI] [PubMed] [Google Scholar]
  47. Madsen-Bouterse S.A., Kowluru R.A. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9:315–327. doi: 10.1007/s11154-008-9090-4. [DOI] [PubMed] [Google Scholar]
  48. Maechler P., Carobbio S., Rubi B. In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion. Int J Biochem Cell Biol. 2006;38:696–709. doi: 10.1016/j.biocel.2005.12.006. [DOI] [PubMed] [Google Scholar]
  49. Maechler P., Li N., Casimir M., Vetterli L., Frigerio F., Brun T. Role of mitochondria in beta-cell function and dysfunction. Adv Exp Med Biol. 2010;654:193–216. doi: 10.1007/978-90-481-3271-3_9. [DOI] [PubMed] [Google Scholar]
  50. Maechler P., Wollheim C.B. Mitochondrial function in normal and diabetic beta-cells. Nature. 2001;414:807–812. doi: 10.1038/414807a. [DOI] [PubMed] [Google Scholar]
  51. Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., Francis J. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res. 2009;85:473–483. doi: 10.1093/cvr/cvp305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mogensen M., Sahlin K., Fernstrom M., Glintborg D., Vind B.F., Beck-Nielsen H., Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 2007;56:1592–1599. doi: 10.2337/db06-0981. [DOI] [PubMed] [Google Scholar]
  53. Mollica M.P., Lionetti L., Crescenzo R., D’Andrea E., Ferraro M., Liverini G., Iossa S. Heterogeneous bioenergetic behaviour of subsarcolemmal and intermyofibrillar mitochondria in fed and fasted rats. Cell Mol Life Sci. 2006;63:358–366. doi: 10.1007/s00018-005-5443-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–273. doi: 10.1038/ng1180. [DOI] [PubMed] [Google Scholar]
  55. Moreira, P.I., and Oliveira, C.R. (2011). Mitochondria as potential targets in antidiabetic therapy. Handb Exp Pharmacol, 331–356. [DOI] [PubMed]
  56. Moreira P.I., Santos M.S., Sena C., Nunes E., Seica R., Oliveira C.R. CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol. 2005;196:112–119. doi: 10.1016/j.expneurol.2005.07.012. [DOI] [PubMed] [Google Scholar]
  57. Moreira P.I., Santos M.S., Sena C., Seica R., Oliveira C.R. Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats. Neurobiol Dis. 2005;18:628–637. doi: 10.1016/j.nbd.2004.10.017. [DOI] [PubMed] [Google Scholar]
  58. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., Neschen S., White M.F., Bilz S., Sono S., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 2005;115:3587–3593. doi: 10.1172/JCI25151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Munusamy S., Saba H., Mitchell T., Megyesi J.K., Brock R.W., Macmillan-Crow L.A. Alteration of renal respiratory Complex-III during experimental type-1 diabetes. BMC Endocr Disord. 2009;9:2. doi: 10.1186/1472-6823-9-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Nishikawa T., Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 2007;9:343–353. doi: 10.1089/ars.2006.1458. [DOI] [PubMed] [Google Scholar]
  61. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790. doi: 10.1038/35008121. [DOI] [PubMed] [Google Scholar]
  62. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376–386. doi: 10.1074/mcp.M200025-MCP200. [DOI] [PubMed] [Google Scholar]
  63. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell. 2008;134:112–123. doi: 10.1016/j.cell.2008.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Pagliarini D.J., Dixon J.E. Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem Sci. 2006;31:26–34. doi: 10.1016/j.tibs.2005.11.005. [DOI] [PubMed] [Google Scholar]
  65. Pan S., Chen R., Aebersold R., Brentnall T.A. Mass spectrometry based glycoproteomics-from a proteomics perspective. Mol Cell Proteomics. 2010;10:R110003251. doi: 10.1074/mcp.R110.003251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100:8466–8471. doi: 10.1073/pnas.1032913100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Patti M.E., Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev. 2010;31:364–395. doi: 10.1210/er.2009-0027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Patton W.F. A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics. Electrophoresis. 2000;21:1123–1144. doi: 10.1002/(SICI)1522-2683(20000401)21:6<1123::AID-ELPS1123>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  69. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664–671. doi: 10.1056/NEJMoa031314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Phillips C.A., Molitch M.E. The relationship between glucose control and the development and progression of diabetic nephropathy. Curr Diab Rep. 2002;2:523–529. doi: 10.1007/s11892-002-0123-1. [DOI] [PubMed] [Google Scholar]
  71. Rabilloud T., Chevallet M., Luche S., Lelong C. Two-dimensional gel electrophoresis in proteomics: Past, present and future. J Proteomics. 2010;73:2064–2077. doi: 10.1016/j.jprot.2010.05.016. [DOI] [PubMed] [Google Scholar]
  72. Rezaul K., Wu L., Mayya V., Hwang S.I., Han D. A systematic characterization of mitochondrial proteome from human T leukemia cells. Mol Cell Proteomics. 2005;4:169–181. doi: 10.1074/mcp.M400115-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes. 2005;54:8–14. doi: 10.2337/diabetes.54.1.8. [DOI] [PubMed] [Google Scholar]
  74. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847–853. doi: 10.1038/nature05483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154–1169. doi: 10.1074/mcp.M400129-MCP200. [DOI] [PubMed] [Google Scholar]
  76. Ruiz-Romero C., Blanco F.J. Mitochondrial proteomics and its application in biomedical research. Mol Biosyst. 2009;5:1130–1142. doi: 10.1039/b906296n. [DOI] [PubMed] [Google Scholar]
  77. Santos J.M., Mohammad G., Zhong Q., Kowluru R.A. Diabetic retinopathy, superoxide damage and antioxidants. Curr Pharm Biotechnol. 2010;12:352–361. doi: 10.2174/138920111794480507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Santos J.M., Tewari S., Goldberg A.F., Kowluru R.A. Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med. 2011;51:1849–1860. doi: 10.1016/j.freeradbiomed.2011.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Satapati S., He T., Inagaki T., Potthoff M., Merritt M.E., Esser V., Mangelsdorf D.J., Kliewer S.A., Browning J.D., Burgess S.C. Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes. 2008;57:2012–2021. doi: 10.2337/db08-0226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Schmeichel A.M., Schmelzer J.D., Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes. 2003;52:165–171. doi: 10.2337/diabetes.52.1.165. [DOI] [PubMed] [Google Scholar]
  81. Shen X., Zheng S., Thongboonkerd V., Xu M., Pierce W.M., Jr., Klein J.B., Epstein P.N. Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab. 2004;287:E896–905. doi: 10.1152/ajpendo.00047.2004. [DOI] [PubMed] [Google Scholar]
  82. Sivitz W.I., Yorek M.A. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 2009;12:537–577. doi: 10.1089/ars.2009.2531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Sparre T., Larsen M.R., Heding P.E., Karlsen A.E., Jensen O.N., Pociot F. Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions. Mol Cell Proteomics. 2005;4:441–457. doi: 10.1074/mcp.R500002-MCP200. [DOI] [PubMed] [Google Scholar]
  84. Suh J.H., Heath S.H., Hagen T.M. Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med. 2003;35:1064–1072. doi: 10.1016/S0891-5849(03)00468-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Suzuki Y., Atsumi Y., Matsuoka K., Nishimaki K., Ohta S., Taniyama M., Muramatsu T. Mitochondrial tRNA(Leu(UUR)) mutation at position 3243 detected in patients with type 1 diabetes. Diabetes Res Clin Pract. 2005;67:92–94. doi: 10.1016/j.diabres.2004.09.010. [DOI] [PubMed] [Google Scholar]
  86. Taylor S.W., Fahy E., Zhang B., Glenn G.M., Warnock D.E., Wiley S., Murphy A.N., Gaucher S.P., Capaldi R.A., Gibson B.W., et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol. 2003;21:281–286. doi: 10.1038/nbt793. [DOI] [PubMed] [Google Scholar]
  87. Tewari S., Santos J.M., Kowluru R.A. Damaged mitochondrial DNA replication system and the development of diabetic retinopathy. Antioxid Redox Signal. 2012;17:492–504. doi: 10.1089/ars.2011.4333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Thomson M. Evidence of undiscovered cell regulatory mechanisms: phosphoproteins and protein kinases in mitochondria. Cell Mol Life Sci. 2002;59:213–219. doi: 10.1007/s00018-002-8417-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Trudeau K., Molina A.J., Guo W., Roy S. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am J Pathol. 2010;177:447–455. doi: 10.2353/ajpath.2010.091029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Turko I.V., Li L., Aulak K.S., Stuehr D.J., Chang J.Y., Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem. 2003;278:33972–33977. doi: 10.1074/jbc.M303734200. [DOI] [PubMed] [Google Scholar]
  91. Turko I.V., Murad F. Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem. 2003;278:35844–35849. doi: 10.1074/jbc.M303139200. [DOI] [PubMed] [Google Scholar]
  92. Turner N., Heilbronn L.K. Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab. 2008;19:324–330. doi: 10.1016/j.tem.2008.08.001. [DOI] [PubMed] [Google Scholar]
  93. Verkhratsky A., Fernyhough P. Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium. 2008;44:112–122. doi: 10.1016/j.ceca.2007.11.010. [DOI] [PubMed] [Google Scholar]
  94. Vial G., Dubouchaud H., Couturier K., Cottet-Rousselle C., Taleux N., Athias A., Galinier A., Casteilla L., Leverve X.M. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J Hepatol. 2010;54:348–356. doi: 10.1016/j.jhep.2010.06.044. [DOI] [PubMed] [Google Scholar]
  95. Wallace D.C. Mitochondrial diseases in man and mouse. Science. 1999;283:1482–1488. doi: 10.1126/science.283.5407.1482. [DOI] [PubMed] [Google Scholar]
  96. Wang Y., Peng F., Tong W., Sun H., Xu N., Liu S. The nitrated proteome in heart mitochondria of the db/db mouse model: characterization of nitrated tyrosine residues in SCOT. J Proteome Res. 2010;9:4254–4263. doi: 10.1021/pr100349g. [DOI] [PubMed] [Google Scholar]
  97. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321. doi: 10.1016/j.diabres.2011.10.029. [DOI] [PubMed] [Google Scholar]
  98. Wiederkehr A., Wollheim C.B. Minireview: implication of mitochondria in insulin secretion and action. Endocrinology. 2006;147:2643–2649. doi: 10.1210/en.2006-0057. [DOI] [PubMed] [Google Scholar]
  99. Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., Straubhaar J., Czech M.P., Corvera S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004;114:1281–1289. doi: 10.1172/JCI21752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Yu T., Sheu S.S., Robotham J.L., Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res. 2008;79:341–351. doi: 10.1093/cvr/cvn104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Zhu W., Smith J.W., Huang C.M. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol. 2010;2010:840518. doi: 10.1155/2010/840518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787. doi: 10.1038/414782a. [DOI] [PubMed] [Google Scholar]
  103. Zischka H., Weber G., Weber P.J., Posch A., Braun R.J., Buhringer D., Schneider U., Nissum M., Meitinger T., Ueffing M., et al. Improved proteome analysis of Saccharomyces cerevisiae mitochondria by free-flow electrophoresis. Proteomics. 2003;3:906–916. doi: 10.1002/pmic.200300376. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES